Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
Zayda Habib, PharmD Candidate
Advertisement
Articles by Zayda Habib, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan
2
Bepirovirsen Shows Breakthrough Potential for Functional Cure in Chronic Hepatitis B
3
Surveys Find Significant Gaps in Public’s Understanding of Shared Decision-Making on Vaccinations
4
Statins in T2D Reduce Mortality, Major CVD Across Spectrum of Cardiovascular Risk
5